Gilead Sciences, Inc.
GILD
$138.92
$0.560.41%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.50B | 2.02B | 2.18B | 3.05B | 1.96B |
| Total Depreciation and Amortization | 698.00M | 689.00M | 687.00M | 686.00M | 691.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.34B | 545.00M | 1.06B | 667.00M | 190.00M |
| Change in Net Operating Assets | 36.00M | -711.00M | -604.00M | -297.00M | -2.01B |
| Cash from Operations | 3.57B | 2.54B | 3.33B | 4.11B | 827.00M |
| Capital Expenditure | -140.00M | -117.00M | -205.00M | -147.00M | -107.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -11.21B | -109.00M | -609.00M | -167.00M | -21.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.00B | 2.00B | -1.02B | -113.00M | -1.99B |
| Cash from Investing | -10.35B | 1.77B | -1.84B | -427.00M | -2.12B |
| Total Debt Issued | 4.09B | -- | -- | -- | -- |
| Total Debt Repaid | -17.00M | -2.77B | -8.00M | -9.00M | -9.00M |
| Issuance of Common Stock | 9.00M | 166.00M | 32.00M | 97.00M | 27.00M |
| Repurchase of Common Stock | -355.00M | -419.00M | -230.00M | -435.00M | -527.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.03B | -1.04B | -994.00M | -1.01B | -994.00M |
| Other Financing Activities | -349.00M | -180.00M | -63.00M | -137.00M | -64.00M |
| Cash from Financing | 2.34B | -4.24B | -1.26B | -1.49B | -1.57B |
| Foreign Exchange rate Adjustments | -19.00M | -11.00M | 5.00M | -5.00M | 73.00M |
| Miscellaneous Cash Flow Adjustments | -1.00M | 1.00M | -- | -1.00M | -- |
| Net Change in Cash | -4.45B | 65.00M | 234.00M | 2.19B | -2.78B |